Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Kaern%2C+J%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Kaern%2C+J%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2003
Mark First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
Kristensen, GB ; Vergote, I ; Stuart, G ; Del Campo, JM ; Kaern, J ; Lopez, AB ; Eisenhauer, E ; Aavall-Lundquist, E ; Ridderheim, Mona ^LU and Havsteen, H , et al. (2003) In International Journal of Gynecological Cancer 13. p.172-177
- Contribution to journal › Article
2000
Mark Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Tropé, C ; Kaern, J ; Hogberg, T ^LU ; Abeler, V ; Hagen, B ; Kristensen, G ; Onsrud, M ; Pettersen, E ; Rosenberg, P and Sandvei, R , et al. (2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281
- Contribution to journal › Article
1998
Mark Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
Tropé, C ; Hogberg, T ^LU ; Kaern, J ; Bertelsen, K ; Bjorkholm, E ; Boman, K ; Himmelmann, A ; Horvath, G ; Jacobsen, A and Kuoppola, T , et al. (1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307
- Contribution to journal › Article